Tagged with M

Philippines Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets, as well as his views on the potential seen in many of the dynamic pharma markets around the world. He…

Philippines Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and multinational companies looking to penetrate new markets. She also discusses her extensive career in the pharmaceutical industry as well as…

USA Take our poll on Donald Trump and Pharma at the bottom of the article Speaking at a White House meeting with senior pharmaceutical executives, US President Donald Trump told drug companies to lower their “astronomical” prices. He pledged to curb regulations and lower tax rates to allow companies to do so,…

Pharma Over the past year, PharmaBoardroom has spoken to many of the global leaders in healthcare logistics from regions as diverse as France, Mexico, Luxembourg, and Singapore. As pharmaceutical and biotech products become more complex and the markets they serve become more diverse; these industry leaders have told us how their…

Switzerland As the largest privately owned pharmaceutical company in Switzerland, IBSA remains committed to continuing to invest and manufacture in Switzerland. Head of Swiss Business Operations Maleša Ulrico Sidjanski, MSc ETH, discusses the company’s current priorities, values, and upcoming investments.   What other mid-sized multinational pharmaceutical companies present in over 80…

Switzerland Jesús Martin-Garcia, Chairman and CEO of GeNeuro, discusses their positive partnership with Servier to develop an antibody against a possible cause of MS, as well as the reasons for choosing Geneva when working with multiple sclerosis. Following 15 years of research performed by French-based Institut Mérieux and INSERM, GeNeuro was…

Ireland Dr. Terry McWade, CEO of Valitacell, discusses the founding of his company, the ground-breaking technology they are producing, and how this technology can help to bring new biologic medications to market faster and more cost-effectively. Having just won the Seedcorn Competition as well as being placed on the list of…

Switzerland Managing volatility – the CEO of Acino, a Swiss pharmaceutical player, elaborates on the company’s unique strategy based on its significant expertise in volatile and uncertain key markets within their regions. Most of your career has been spent with mid-cap and big pharmaceutical companies. Three years ago, you decided to…

Angelini Having joined the company at the onset of its presence in the Greek market, Angelini Pharma Hellas’s General Manager, Panagiotis Giannouleas, speaks about the success of the company’s transitional period, how Angelini is maneuvering through current local uncertainties, and his overarching vision for the future. Mr. Giannouleas, having hailed from…

Singapore The Big Picture Singapore’s real GDP per person has grown incredibly since independence in 1965, helping the country make the leap from third world to first world in less than half a century. Switzerland is the world’s leading nation for investor friendliness in terms of ease of doing business, labour…

Taiwan The co-founder and president of Mycenax Biotech, Dr. Karen Wen details the key lessons learned from the development of their first in-house product TuNEX® and how they have been applied to their second flagship product LusiNEX (tocilizumab). She also details the company’s transition from a platform-driven service provider to a…

Switzerland The Services Delivery Director for Life Sciences of NNIT Switzerland talks big data and highlights how this trend needs to be approached in order to create value for companies in the life science industry. You first joined NNIT in 2010; you then moved to the FMCG sector for a few…